About us
  Contact
  Study Office
  Study Coordinating Group
  Executive Board
  Open Trials
  Closed Trials
  Publicized Trials
  General
  Study Planning
  Study Implementation
  Study Completion
  Roadshow
  Guidelines
  Guidebook
  Statements
  Press Releases
  Co-operation partners
  National
  International
  other Links
The AGO Study Group is a non-profit organisation with the aim to enhance the therapy of pelvic tumours in women. It developed from the AGO Ovarian Cancer Study Group, which was founded in 1993.
Presentations 15th Annual Meeting 2007


- Regeln der AGO Studiengruppe
- Update der Studien im Follow up
- AGO-OVAR 11
- AGO-OVAR 11t- HISTO
- AGO-OVAR 10
- AGO-OVAR OP.3/LION
- AGO-OVAR 2.9/CALYPSO
- AGO-OVAR 2.12/HECTOR
- AGO-OVAR 2.11
- AGO GYN 6
- AGO-OVAR OP.2/DESKTOP II
- AGO GYN 5
- AGO GYN 7
- AGO Zervix 1
- HER2 neu
- Elderly Patients
- Immunologische Ansätze
- 15 Jahre AGO Studiengruppe - Rück- und Ausblick






- Primärtherapie
- Rezidivtherapie




German Version | Sitemap | Suche | Impressum | Kontakt
© AGO Studiengruppe 2008